Compare LEXX & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | AUID |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.3M |
| IPO Year | 2011 | 2014 |
| Metric | LEXX | AUID |
|---|---|---|
| Price | $3.84 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.3K | ★ 1.1M |
| Earning Date | 11-27-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $2,040,660.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 52.05 | ★ 130.20 |
| 52 Week Low | $0.35 | $0.22 |
| 52 Week High | $21.60 | $2.82 |
| Indicator | LEXX | AUID |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 36.03 |
| Support Level | $2.67 | N/A |
| Resistance Level | $3.90 | $0.36 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.24 | -0.00 |
| Stochastic Oscillator | 88.56 | 15.90 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
AuthID Inc is a company engaged in ensuring enterprises - Know Who's Behind the Device, for every customer or employee login and transaction, through its easy-to-integrate, patented, biometric identity platform. authID powers biometric identity proofing, biometric authentication, and account recovery with a fast, accurate, user-friendly experience. With its PrivacyKey solution, authID provides accurate biometric authentication while storing no biometric data. authID's goal is to stop fraud at onboarding, blocks deepfakes, prevents account takeover, and eliminates password risks and costs, through the faster, and accurate user identity experience demanded by the digital ecosystem Its products are: IDX Mandate for Agentic AI, PrivacyKey, Identity Verification, and Biometric Authentication.